Search Results 501-510 of 19020 for creatine

1. Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma - Mayo Clinic

   Creatinine < 2.0 × ULN; Hepatic function: Conjugated bilirubin <1.5 × ULN and ALT and AST <3 × ULN. Has a QT interval corrected by Fridericia's formula (QTcF) ...

2. Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy - Mayo Clinic

   ... Creatinine ≤ 2.5 x ULN). Exclusion Criteria: Patients eligible for this study must not meet any of the following criteria: Prior therapy for AML with the ...

3. A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) - Mayo Clinic

   Estimated creatinine clearance ≥ 30 mL/min based on Cockcroft-Gault 7. Urine protein ≤ 1+ by Dipstick (Only when urinalysis shows a protein dipstick ...

4. Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine - Mayo Clinic

   Serum creatinine ≥ 2.0 mg/dL. Ascites requiring active medical management including paracentesis, or hyponatremia (defined as serum sodium value of <130 ...

5. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

   Serum creatinine ≤ 1.5 x ULN or 24-hour clearance ≥ 50 mL/min; Magnesium ≥ lower limit of normal (LLN); Potassium ≥ LLN; Serum amylase ≤ ULN; Serum lipase ...

6. S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer - Mayo Clinic

   Serum creatinine level ≤ IULN; Fasting cholesterol ≤ 300 mg/dL and triglycerides ≤ 2.5 times IULN; patients may be on lipid-lowering agents to reach these ...

7. An Efficacy Study Comparing Oral Ixazomib/Dexamethasone and Oral Pomalidomide/Dexamethasone in Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   Calculated creatinine clearance ≥0 mL/min (see Section 9.4.15.1). Female patients who: Are postmenopausal for at least 1 year before the Screening Visit ...

8. A Study of Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with MCL-1 Dependence ≥ 40% - Mayo Clinic

   Have a serum creatinine level ≤ 1.8 mg/dL. Have an alanine aminotransferase (ALT)/aspartate aminotransferase (AST) level ≤ 5 times upper limit of normal ...

9. S1400 Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer - Mayo Clinic

   Serum creatinine =< the IULN OR measured or calculated creatinine clearance >= 50 mL/min using the following Cockcroft-Gault Formula within 28 days prior to ...

10. T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer - Mayo Clinic

    - Creatinine =< 1.5 x upper limit of normal (ULN) - Total bilirubin =< 1.0 x upper limit of normal (ULN) or direct bilirubin within the institutional normal ...